BACKGROUND AND AIM: At the same time that Helicobacter pylori prevalence is declining in Western countries, immigrants from developing countries with high H. pylori prevalence have settled in Western urban areas. Actual epidemiological data on H. pylori in a migrant community may help in realizing a more selective approach to assess H. pylori-related diseases. We aimed to define H. pylori prevalence as well as risk groups for H. pylori in a cohort of young women living in a multi-ethnic European city. METHODS: We measured Immunoglobulin G (IgG) anti-H. pylori and CagA-antibodies in serum of pregnant women included in a population-based prospective cohort study, the Generation R study. Information on demographics and socioeconomic status was collected by questionnaires. Chi-square and logistic regression were used. RESULTS: In total, 3146 (46%) of the 6837 tested women (mean age 29.7 ± 5.3) were H. pylori-positive and 1110 (35%) of them were CagA-positive. The H. pylori prevalence in Dutch women was 24%, which was significantly lower than in non-Dutch women (64%; P < 0.001). In particular, H. pylori positivity was found in 92% of Moroccan (odds ratio 19.2; 95% confidence interval 11.8-32.0), 80% of Cape Verdean (7.6; 5.0-11.5), 81% of Turkish (9.0; 6.7-12.1), 60% of Dutch Antillean (3.3; 2.3-4.7), and 58% of Surinamese women (3.0; 2.3-3.8). Among H. pylori-positive Dutch subjects, 19% were CagA-positive compared with 40% of the non-Dutch subjects (P < 0.001). CONCLUSIONS: Despite a general trend of declining prevalence in Western countries, H. pylori remains highly prevalent in migrant communities, which may constitute target groups for screening and eradication to prevent H. pylori-related diseases.
BACKGROUND AND AIM: At the same time that Helicobacter pylori prevalence is declining in Western countries, immigrants from developing countries with high H. pylori prevalence have settled in Western urban areas. Actual epidemiological data on H. pylori in a migrant community may help in realizing a more selective approach to assess H. pylori-related diseases. We aimed to define H. pylori prevalence as well as risk groups for H. pylori in a cohort of young women living in a multi-ethnic European city. METHODS: We measured Immunoglobulin G (IgG) anti-H. pylori and CagA-antibodies in serum of pregnant women included in a population-based prospective cohort study, the Generation R study. Information on demographics and socioeconomic status was collected by questionnaires. Chi-square and logistic regression were used. RESULTS: In total, 3146 (46%) of the 6837 tested women (mean age 29.7 ± 5.3) were H. pylori-positive and 1110 (35%) of them were CagA-positive. The H. pylori prevalence in Dutch women was 24%, which was significantly lower than in non-Dutch women (64%; P < 0.001). In particular, H. pylori positivity was found in 92% of Moroccan (odds ratio 19.2; 95% confidence interval 11.8-32.0), 80% of Cape Verdean (7.6; 5.0-11.5), 81% of Turkish (9.0; 6.7-12.1), 60% of Dutch Antillean (3.3; 2.3-4.7), and 58% of Surinamese women (3.0; 2.3-3.8). Among H. pylori-positive Dutch subjects, 19% were CagA-positive compared with 40% of the non-Dutch subjects (P < 0.001). CONCLUSIONS: Despite a general trend of declining prevalence in Western countries, H. pylori remains highly prevalent in migrant communities, which may constitute target groups for screening and eradication to prevent H. pylori-related diseases.
Authors: Frank Heuberger; Draha Pantoflickova; Markus Gassner; Carl Oneta; Michael Grehn; André L Blum; Gian Dorta Journal: Eur J Gastroenterol Hepatol Date: 2003-02 Impact factor: 2.566
Authors: G I Perez-Perez; A Salomaa; T U Kosunen; B Daverman; H Rautelin; A Aromaa; P Knekt; M J Blaser Journal: Gut Date: 2002-03 Impact factor: 23.059
Authors: Maria P Dore; Hoda M Malaty; David Y Graham; Giuseppe Fanciulli; Giuseppe Delitala; Giuseppe Realdi Journal: Clin Infect Dis Date: 2002-07-08 Impact factor: 9.079
Authors: M J Blaser; G I Perez-Perez; H Kleanthous; T L Cover; R M Peek; P H Chyou; G N Stemmermann; A Nomura Journal: Cancer Res Date: 1995-05-15 Impact factor: 12.701
Authors: Claudia J Kruithof; Marjolein N Kooijman; Cornelia M van Duijn; Oscar H Franco; Johan C de Jongste; Caroline C W Klaver; Johan P Mackenbach; Henriëtte A Moll; Hein Raat; Edmond H H M Rings; Fernando Rivadeneira; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Eppo B Wolvius; Albert Hofman; Vincent W V Jaddoe Journal: Eur J Epidemiol Date: 2014-12-21 Impact factor: 8.082
Authors: Jorie Buijs; Djuna L Cahen; Marianne J van Heerde; Bettina E Hansen; Henk R van Buuren; Maikel P Peppelenbosch; Gwenny M Fuhler; Marco J Bruno Journal: Am J Gastroenterol Date: 2016-06-21 Impact factor: 10.864
Authors: Wouter J den Hollander; Sarah Schalekamp-Timmermans; I Lisanne Holster; Vincent W Jaddoe; Albert Hofman; Henriëtte A Moll; Guillermo I Perez-Perez; Martin J Blaser; Eric A P Steegers; Ernst J Kuipers Journal: Helicobacter Date: 2016-10-27 Impact factor: 5.753
Authors: W J den Hollander; A M M Sonnenschein-van der Voort; I L Holster; J C de Jongste; V W Jaddoe; A Hofman; G I Perez-Perez; H A Moll; M J Blaser; L Duijts; E J Kuipers Journal: Aliment Pharmacol Ther Date: 2016-03-01 Impact factor: 8.171
Authors: Wouter J den Hollander; I Lisanne Holster; Bianca van Gilst; Anneke J van Vuuren; Vincent W V Jaddoe; Albert Hofman; Guillermo I Perez-Perez; Ernst J Kuipers; Henriëtte A Moll; Martin J Blaser Journal: Gut Date: 2014-08-28 Impact factor: 23.059